Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

67
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
67
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

43
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
43
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

587
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
587
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

89
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
89
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

54
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
54
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

32
Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
32

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Benzene-induced pulmonary dysfunction in diabetic mice.

Toxicological sciences : an official journal of the Society of Toxicology·2026
Same author

A unified liquid chromatography-mass spectrometric approach combining targeted and untargeted analyses for community exposure profiling in wastewater.

Environment international·2026
Same author

A phase 2 randomized controlled trial of luvadaxistat in treatment of adults with cognitive impairment associated with schizophrenia: results from the ERUDITE study.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Same author

Predictive modelling of Uranium (<sup>238</sup>U) and Thorium (<sup>232</sup>Th) in soils of Central India: integrating ICP-MS/MS, spectroscopic, and machine learning models.

Scientific reports·2026
Same author

Neuroplasticity-Based Targeted Cognitive Training as Enhancement to Social Skills Program: A Randomized Controlled Trial Investigating a Novel Digital Application for Autistic Adolescents.

JAACAP open·2026
Same author

Relations of residential greenness with immunity and inflammation.

Environmental research·2026
Same journal

Correction: Jiménez-Sánchez et al. Antioxidant Enzymes Genetic Variants Associated with Urticaria/Angioedema Induced by Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs. <i>Pharmaceuticals</i> 2026, <i>19</i>, 522.

Pharmaceuticals (Basel, Switzerland)·2026
Same journal

Correction: Zhao et al. Multifunctional Gel Films of Marine Polysaccharides Cross-Linked with Poly-Metal Ions for Wound Healing. <i>Pharmaceuticals</i> 2022, <i>15</i>, 750.

Pharmaceuticals (Basel, Switzerland)·2026
Same journal

Intravenous Immunoglobulin Reveals a Novel Protective Mechanism: Targeting the GBP5-Driven Pyroptosis Axis in Experimental Colitis.

Pharmaceuticals (Basel, Switzerland)·2026
Same journal

Icariin Attenuates Renal Injury in Streptozotocin-Induced Diabetic Rats with and Without Adenine-Induced Chronic Kidney Disease.

Pharmaceuticals (Basel, Switzerland)·2026
Same journal

AI-Assisted Identification of a Putative Allosteric Ligand Targeting the CDK4/Cyclin D1 Protein-Protein Interface.

Pharmaceuticals (Basel, Switzerland)·2026
Same journal

Development and Study of Hydrophilic Ointment Compositions with a Dextrin/Polyvinyl Alcohol/Iodine Complex (D/PVA/I).

Pharmaceuticals (Basel, Switzerland)·2026
查看所有相关文章

相关实验视频

Updated: Jun 6, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
07:58

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

8.8K

人工智能和机器学习模型用于预测小分子中药物诱导的损伤.

Mohan Rao1, Vahid Nassiri2, Sanjay Srivastava1

  • 1Preclinical and Clinical Pharmacology and Chemistry, Neurocrine Biosciences, San Diego, CA 92130, USA.

Pharmaceuticals (Basel, Switzerland)
|November 27, 2024
PubMed
概括
此摘要是机器生成的。

这项研究开发了一种AI/ML模型,整合了药物特性和相互作用,以预测药物诱导的损伤 (DIKI). 该模型增强了早期识别具有较低DIKI风险的化合物,提高了药物安全性和开发效率.

关键词:
人工智能的人工智能是人工智能.化学信息学 化学信息学计算毒理学计算毒理学药物诱导的损伤导致损伤.机器学习是机器学习.目标之外的相互作用.

更多相关视频

Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice
02:45

Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice

Published on: February 2, 2024

1.4K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.3K

相关实验视频

Last Updated: Jun 6, 2025

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury
07:58

Nephrotoxin Microinjection in Zebrafish to Model Acute Kidney Injury

Published on: July 17, 2016

8.8K
Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice
02:45

Bilateral Renal Ischemia-Reperfusion Model for Acute Kidney Injury in Mice

Published on: February 2, 2024

1.4K
Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro
11:06

Human Liver Microphysiological System for Assessing Drug-Induced Liver Toxicity In Vitro

Published on: January 31, 2022

4.3K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 计算化学计算化学
  • 药物开发 药物开发

背景情况:

  • 药物诱导损伤 (DIKI) 是药物开发中的一个主要障碍,导致晚期失败.
  • 当前的预测模型往往忽略了关键的药物向相互作用,只关注物理化学性质.
  • 早期DIKI风险评估对于提高药物安全性和简化开发至关重要.

研究的目的:

  • 开发一个先进的AI/ML模型来预测DIKI风险.
  • 整合物理化学性质和非目标药物相互作用,以提高预测准确度.
  • 创建一个工具,用于早期选具有降低DIKI潜力的化合物.

主要方法:

  • 编制了360种FDA分类化合物的数据集 (129种是毒性,231种是非毒性).
  • 分析了物理化学性质 (55) 和验证的体外非标相互作用 (6064).
  • 构建了一个整体机器学习模型,结合了Ridge逻辑回归,支持矢量机器,随机森林和神经网络.

主要成果:

  • 整体模型实现了0.86的ROC-AUC,灵敏度为0.79和特异性为0.78.
  • 关键预测因素包括特定的目标外相互作用和物理化学性质,如PSA,pKa和fsp3.
  • 综合方法有效地将DIKI诱导化合物与非DIKI化合物区分开来.

结论:

  • 将物理化学性质与目标外相互作用数据相结合,可显著提高DIKI预测的准确性.
  • 开发的AI/ML模型是用于早期识别具有较低DIKI风险的化合物的宝贵工具.
  • 这种方法有望提高药物安全性,加快药物开发过程.